Valiant Laboratories Limited Financial Ratios
VALIANTLAB · Healthcare · Current price ₹134.65
P/E ratio
42.3x
P/B ratio
2.2x
ROE
-1.1%
ROCE
0.7%
Debt / Equity
0.15
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 42.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -1.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 0.7% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.15 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Valiant Laboratories Limited's latest numbers.
Valiant Laboratories Limited profitability
Valiant Laboratories Limited generates a return on equity of -1.1% and a return on capital employed of 0.7%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.15 and a P/E of 42.3x, Valiant Laboratories Limited is conservatively financed. Our overall business-quality score for the company is 2.7 / 10.
Understand the ratios
More on Valiant Laboratories Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.